文献速递中毒与环境急症

活性炭适口性研究:添加剂能否改善味道、吞咽难易度和耐受性?

Activated charcoal palatability study: do additives improve taste, ease of swallowing, and tolerability?
PubMed 文献 · Clin Toxicol (Phila) · 2026-07-22
一句话结论在健康志愿者中,活性炭与巧克力奶按4:1混合时全剂量接受率最高(58%),味道是全剂量意愿的显著预测因素。

单中心交叉研究纳入60名健康成人,随机顺序品尝活性炭与水和巧克力奶、苹果汁、冰淇淋按4:1比例混合的样品,15分钟洗脱期,用10分视觉模拟量表评分味道和吞咽难易度,并表明是否愿意服用完整50克(250 mL)剂量。巧克力奶味道评分最高(均值5.57,SD 2.28,P<0.05),冰淇淋吞咽难易度评分最低(均值3.55,SD 2.08,P<0.05)。全剂量接受率巧克力奶最高(58%)、冰淇淋最低(35%),两者差异显著(P=0.03)。巧克力奶组味道是全剂量意愿的显著预测因素(OR=1.81,P=0.02),女性比男性更可能接受巧克力奶全剂量(OR=3.92,P=0.04)。

要点

  • 健康志愿者中,活性炭与巧克力奶按4:1混合的全剂量(50克/250 mL)接受率为58%,高于冰淇淋的35%(P=0.03)。
  • 巧克力奶混合后味道评分最高,均值5.57(SD 2.28),P<0.05;冰淇淋吞咽难易度评分最低,均值3.55(SD 2.08),P<0.05。
  • 味道是巧克力奶组全剂量服用意愿的显著预测因素(OR=1.81,P=0.02)。
  • 女性比男性更可能接受巧克力奶混合的活性炭全剂量(OR=3.92,P=0.04)。
  • 该研究为健康志愿者交叉设计,结果不能直接推导为中毒患者的临床推荐。

适用人群与场景

  • 健康成人志愿者60名,男性29名(48.3%),中位年龄22岁(IQR 21-23岁,范围18-44岁);非中毒患者,非急诊或ICU人群。

诊断标准与关键阈值

  • 味道和吞咽难易度采用10分视觉模拟量表评分;全剂量接受定义为愿意服用完整50克(250 mL)活性炭剂量。
  • 活性炭与添加剂按4:1比例混合,添加剂包括水、巧克力奶、苹果汁或冰淇淋。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 单中心交叉研究,60名健康成人,随机顺序品尝4种活性炭混合物(水、巧克力奶、苹果汁、冰淇淋,4:1比例),15分钟洗脱期。
  • 巧克力奶味道评分最高,均值5.57(SD 2.28),P<0.05;冰淇淋吞咽难易度评分最低,均值3.55(SD 2.08),P<0.05。
  • 全剂量(50克/250 mL)接受率:巧克力奶58%最高,冰淇淋35%最低,两者差异显著(P=0.03)。
  • 味道是巧克力奶组全剂量意愿的显著预测因素(OR=1.81,P=0.02);女性比男性更可能接受巧克力奶全剂量(OR=3.92,P=0.04)。

证据类型、等级与局限

  • 单中心、交叉设计、健康志愿者研究,样本量60,非中毒患者人群,未报告证据等级或推荐强度。
  • 局限:单中心、健康志愿者替代中毒患者、未设盲描述、样本量小、年龄集中(中位22岁),结果外推至急诊中毒患者需谨慎。

对床旁实践的改变

  • 在健康志愿者中,巧克力奶按4:1与活性炭混合可提高全剂量接受率至58%,但该结果来自非中毒人群,不能直接改变急诊中毒患者的活性炭给药常规。
  • 味道评分与全剂量意愿相关(巧克力奶组OR=1.81),提示改善适口性可能有助于提高依从性,但需在中毒患者中前瞻性验证。
  • 冰淇淋混合的吞咽难易度评分最低(均值3.55),全剂量接受率最低(35%),不推荐作为改善适口性的选择(仅限本研究志愿者数据)。

指南或共识出处

  • 原文未提及指南或共识名称;研究发表于Clin Toxicol (Phila)。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

INTRODUCTION: Activated charcoal is the most widely used gastrointestinal decontaminant in poisoning. Its clinical benefit relies on patients ingesting an adequate dose, yet poor palatability often limits compliance. Enhancing taste and ease of swallowing may improve adherence. This study examines whether mixing activated charcoal with chocolate milk, apple juice, or ice cream improves palatability and willingness to consume a full therapeutic dose.

METHODS: A single-centre, crossover study involved 60 healthy adults tasting activated charcoal mixed in a 4:1 charcoal-to-additive ratio with water, chocolate milk, apple juice, or ice cream, in random order, with a 15-min washout period. After each tasting, participants rated taste and ease of swallowing on a 10-point visual analogue scale and indicated willingness to consume a full 50-gram dose (250 mL). Data were analysed using repeated-measures ANOVA, Cochran's Q, and regression models.

RESULTS: Sixty volunteers participated, 29 (48.3%) male, median age 22 years (IQR: 21-23 years, range: 18-44 years). Chocolate milk had the highest mean rating 5.57 (SD: 2.28) (P <0.05). For ease of swallowing, ice cream had the lowest mean rating 3.55 (SD: 2.08) (P <0.05). Full-dose acceptance was highest with chocolate milk (58%) and lowest with ice cream (35%), with a significant difference between them (P = 0.03). Taste was a significant predictor of full-dose willingness for chocolate milk (OR = 1.81, P = 0.02). Women were more likely than men to accept a full dose with chocolate milk (OR = 3.92, P = 0.04).

DISCUSSION: Our findings align with previous studies showing that additives improve activated charcoal palatability, with chocolate milk preferred over apple juice, ice cream, and water. Importantly, we assessed willingness to consume a full dose, a novel and clinically relevant measure of adherence and chocolate milk showed the highest willingness.

CONCLUSION: In this volunteer study, chocolate milk significantly improved charcoal acceptance. Taste influenced full-dose willingness across additives, suggesting a role in optimising activated charcoal administration.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Go K, Krishnamohan A, Chiew AL, et al. Activated charcoal palatability study: do additives improve taste, ease of swallowing, and tolerability? Clin Toxicol (Phila). 2026. PMID: 42484358. doi:10.1080/15563650.2026.2699332

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。